Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.
-
Upload
jeffery-vick -
Category
Documents
-
view
234 -
download
3
Transcript of Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.
![Page 1: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/1.jpg)
Adverse Events and Serious Adverse Events
Office of Research Education and Regulatory Management
![Page 2: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/2.jpg)
Objectives
• Recognize Adverse Events and serious adverse events
• Review FDA inspection findings related to adverse events
• Review regulations related to adverse events• Discuss recording and reporting of adverse
events• Discuss auditing of adverse events• Demonstrate audit of adverse events
![Page 3: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/3.jpg)
FDA Inspection
• “Failure to prepare and submit complete and accurate and timely reports of unanticipated adverse device effects”
![Page 4: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/4.jpg)
Recognizing
![Page 5: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/5.jpg)
Adverse Events
• Any adverse event associated with the use of a drug in humans, whether or not considered related.– 21CFR 314.80
• Any untoward medical occurrence in a patient administered a pharmaceutical product and which does not necessarily have a causal relationship with the treatment– ICH E6
![Page 6: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/6.jpg)
Adverse Event
• NCI– An unexpected medical problem that occurs
during treatment with a drug or other therapy.– Adverse events do not have to be a caused by the
drug or therapy
![Page 7: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/7.jpg)
Serious Adverse Event
Fred Doesn’t Have Any Money Left
FatalDisabilityHospitalizationAnomalyMedically SignificantLife Threatening
![Page 8: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/8.jpg)
Expected Vs. Unexpected
• Expected– Known to Occur and is
Listed in the Investigational Brochure, Informed Consent, or General Investigational Plan
• Unexpected– Not listed in
Investigational Brochure, Informed Consent, or General Investigational Plan
– Also not listed in a drug package insert
![Page 9: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/9.jpg)
Recording
![Page 10: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/10.jpg)
Recording
• Know which adverse events the protocol requires to be captured
![Page 11: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/11.jpg)
Source Documentation• Source Documentation of adverse events include
documentation in the medical records of:– Event– Date it occurred– Grade as determined by CTCAE– Expected or Unexpected– Attribution as assigned by PI– Date resolved– Treatment patient received specifically related to
event
![Page 12: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/12.jpg)
Sample Adverse Event Recording Form
• See template behind this presentation
![Page 13: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/13.jpg)
![Page 14: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/14.jpg)
Attribution (Causality)
• The attribution (relationship or causality or drug related assessment) must be determined
• A determination made by a clinical investigator that describes the relationship or association of the study product with an adverse experience
• This determination must be recorded both in the medical record as well as in the case report form.
![Page 15: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/15.jpg)
Attribution
• What should the investigator consider prior to assigning attribution?– Individual medical history – Known effects of concomitant medications
![Page 16: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/16.jpg)
Attribution
• Definite – Clearly related to study agent• Probable – Likely related to study agent• Possible – May be related to study agent• Unlikely – Doubtfully related to study agent• Unrelated – Clearly not related to study agent
![Page 17: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/17.jpg)
How to Capture Adverse Events?
• Split or Lumped– Fever, Diarrhea, and Vomiting (Viral
Gastroenteritis)– Cough, Sniffles, Sore throat (Flu)
![Page 18: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/18.jpg)
How to Capture Adverse Events?
• Problems with similar terms– Rash or Dermatitis– Wheezing, reactive airway disease, congestion,
cold, , asthma
![Page 19: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/19.jpg)
Documenting Resolution Dates
• Challenge– Does the patient remember when their adverse
event resolved?– Do you call the patient? Or wait till the next visit?
![Page 20: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/20.jpg)
Patient Toxicity Diary
• Diaries where patients capture toxicities between their follow up appointments
![Page 21: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/21.jpg)
Patient Toxicity Diaries
• Patient writes down constipation because he did not have a bowel movement one day– Research nurse captures constipation without
assessing further– Physician copies the research nurse’s note and also
dictates constipation• Did anyone ask about the constipation?– According to CTC V3, constipation is grade 1 only if
there is occasional or intermittent symptoms; occasional use of stool softeners, laxatives, dietary modification, or enema
![Page 22: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/22.jpg)
Patient Adverse Event Diaries
Advantages• Allows capturing
information on a daily basis while patient is away from clinic
• A communication tool for patient returns to clinic
• Useful in capturing onset and resolution dates of adverse events
Disadvantages• Time consuming• Patient non-compliance• Patient self diagnosis or
interpretation • Complicated Instructions
![Page 23: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/23.jpg)
Question to ask
• When should site staff begin collecting adverse event information?
![Page 24: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/24.jpg)
Question to ask
• How long should one collect adverse events after the subject completes study treatment?
![Page 25: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/25.jpg)
Reporting
![Page 26: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/26.jpg)
Reporting Serious Events
• An investigator must promptly report to the sponsor any adverse effect that may reasonably be regarded as caused by or probably caused by the drug. If the adverse effect is alarming, the investigator shall report the adverse effect immediately.– 21CFR312.64
![Page 27: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/27.jpg)
Reporting Criteria
• Routine Reporting– Know which events can be reported at interim
analysis or annual reviews
• Expedited Reporting– Know which events require immediate reporting
![Page 28: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/28.jpg)
Reporting Criteria
• Know which type of expedited reports each regulatory body requires– FDA– Sponsor– Co-Sponsor– MD Anderson– NCI– Collaborative Groups
![Page 29: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/29.jpg)
Issues in reporting
• Primary events– Example• Patient admitted with Congestive Heart Failure• Subsequently develops: Pulmonary Edema and
Cardiogenic Shock
![Page 30: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/30.jpg)
Consequences of Improper Reporting
• Protocol Violations• IRB will close protocol• FDA Hold• Sponsor Hold• Research Privileges Revoked• Patient Safety
![Page 31: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/31.jpg)
Auditing
![Page 32: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/32.jpg)
Auditing Check Points
• How are AEs being recorded in the medical record?
• Does documentation include grade, onset, resolution, and attribution?
![Page 33: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/33.jpg)
Auditing Check Points
• Were all toxicities included?• Was the proper CTCAE version used for the
protocol?• Were the toxicities graded appropriately?
![Page 34: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/34.jpg)
Auditing Check Points
• Was the event a dose limiting toxicity?• Should the dose have been reduced?• If so, did the research team realize it as such
and identify it correctly?
![Page 35: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/35.jpg)
Auditing
• Are adverse events appropriately reported within the time periods required by regulations, sponsor, and IRB policies?
![Page 36: Adverse Events and Serious Adverse Events Office of Research Education and Regulatory Management.](https://reader036.fdocuments.in/reader036/viewer/2022062303/551a91095503466b3a8b4f29/html5/thumbnails/36.jpg)
We have reviewed……….
• Recognizing adverse events and serious adverse events
• Inspections and findings related to adverse events
• Regulations related to adverse events• Recording and reporting of adverse events• Auditing of adverse events